A Phase 3, Prospective, Multicenter, Randomized, Controlled Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A Inhalation Solution Delivered via the PARI Investigational eFLOW Device plus Standard of Care in the Treatme

  • Nandavaram, Sravanthi (PI)
  • Rockich, Anna (CoI)
  • Baz, Maher (Former PI)
  • Sekela, Michael (Former PI)

Grants and Contracts Details

StatusActive
Effective start/end date5/24/1912/13/24

Funding

  • Covance: $113,091.00